Cite
HARVARD Citation
Genovese, M. et al. (2020). MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study. Lancet. pp. e666-e676. [Online].